Trial reportSurgical endoscopy2026
Effect of intraoperative autonomic neural blockade on early postoperative outcomes after laparoscopic cholecystectomy: a double-blind randomized controlled trial.
Trial report in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07655908 (Targeted Temporary In Situ Catheter Redosing of Autonomic Neural Blockade for Breakthrough Symptoms After Laparoscopic Sleeve Gastrectomy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Targeted Temporary In Situ Catheter Redosing of Autonomic Neural Blockade for Breakthrough Symptoms After Laparoscopic Sleeve Gastrectomy
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvances in minimally invasive techniques, enhanced recovery protocols, and regional pain management have improved postoperative outcomes. However, visceral pain and postoperative nausea and vomiting (PONV) continue to be challenging after minimally invasive procedures. Intraoperative autonomic neural blockade (ANB), which interrupts the afferent nerves transmitting these impulses, has effectively addressed these challenges, as demonstrated in previous publications. This randomized trial evaluates its efficacy in laparoscopic cholecystectomy.
methodsIn this double-blind, randomized controlled trial, 62 patients undergoing elective laparoscopic cholecystectomy were assigned to receive ANB with Bupivacaine and Dexamethasone (intervention group) or no blockade (control group). All patients received standard TAP, subcostal blocks, low-pressure pneumoperitoneum, and ERAS-based care. The primary outcome was Acetaminophen consumption. Rescue analgesic use was assessed at 1, 24, and 48 h postoperatively. Secondary outcomes included pain scores at 1, 24, and 48 h and the incidence of nausea and vomiting.
resultsBaseline characteristics were similar between groups. Pain scores were significantly lower in the ANB group at 1, 24, and 48 h (0.42 vs. 2.52 at 1h; p < 0.0001). Acetaminophen consumption was markedly reduced over 48 h (0.42 vs. 2.33 doses; p < 0.0001). Fewer patients required NSAIDs or Codeine rescue analgesia, and nausea/vomiting was less frequent in the ANB group. No adverse events were reported.
conclusionsThis study demonstrates that ANB significantly reduces the analgesic requirements and autonomic symptoms after laparoscopic cholecystectomy, even when added to comprehensive multimodal care. These findings support its broader use in minimally invasive surgery (MIS), where autonomic afferent input predominates by targeting the appropriate pathways.
Indexed as
Identifiers
41530355What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.